- Direction
- Unknown
- Own history
- —
- Peers
- —
- Persistence
- TRANSIENT
· Laboratory Analytical Instruments
RESEARCH SNAPSHOTAlamar Biosciences, Inc.'s latest supported as-filed period reports revenue of $33.5M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.38% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -43.92% · OPTIONAL
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 161.37% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 61.54% · CORE
Level · gp.fundamentals.operating_margin
Raw value -45.13% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 48.20% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Each point keeps the date investors could first observe it and its accession.
ALMR · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001231919-26-001575SEC ↗4Nov 5, 2026Period Nov 3, 20260001231919-26-001540SEC ↗10-QNov 4, 2026Period Sep 30, 20260001193125-26-445905SEC ↗4Nov 3, 2026Period Oct 30, 20260001231919-26-001531SEC ↗8-KNov 3, 2026Period Oct 30, 20260001193125-26-445353SEC ↗4Oct 29, 2026Period Oct 27, 20260001231919-26-001508SEC ↗4Oct 27, 2026Period Oct 23, 20260001231919-26-001501SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 1,694 | $29 | $49,702 | Form 4 ↗ |
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 56 | $31 | $1,715 | Form 4 ↗ |
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 62,944 | $29 | $1.8M | Form 4 ↗ |
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 2,084 | $31 | $63,833 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 11.67% · OPTIONAL
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001231919-26-001497| Nov 11, 2026Filed Nov 13, 2026 |
| Qiming Corporate GP VI, Ltd.Reporting owner |
| Open Market SaleIndirect |
| 14,687 |
| $29 |
| $430,917 |
| Form 4 ↗ |
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 486 | $31 | $14,886 | Form 4 ↗ |
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 17,584 | $29 | $515,915 | Form 4 ↗ |
| Nov 11, 2026Filed Nov 13, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 582 | $31 | $17,827 | Form 4 ↗ |
| Nov 3, 2026Filed Nov 5, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 1,946 | $30 | $58,166 | Form 4 ↗ |
| Nov 3, 2026Filed Nov 5, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 72,301 | $30 | $2.2M | Form 4 ↗ |
| Nov 3, 2026Filed Nov 5, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 16,870 | $30 | $504,244 | Form 4 ↗ |
| Nov 3, 2026Filed Nov 5, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 20,196 | $30 | $603,658 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 763 | $30 | $22,768 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 3 | $31 | $92 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 28,404 | $30 | $847,575 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 131 | $31 | $4,013 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 6,628 | $30 | $197,780 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 30 | $31 | $919 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 7,935 | $30 | $236,780 | Form 4 ↗ |
| Nov 2, 2026Filed Nov 3, 2026 | Qiming Corporate GP VI, Ltd.Reporting owner | Open Market SaleIndirect | 36 | $31 | $1,103 | Form 4 ↗ |